Log In
Print
BCIQ
Print
Print this Print this
 

Therascreen K-RAS, Therascreen KRAS RGQ PCR Kit

  Manage Alerts
Collapse Summary General Information
Company Qiagen N.V.
DescriptionColorectal cancer diagnostic kit which detects mutations in codons 12 and 13 of the K-Ras gene
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify K-Ras mutation status to predict response to anti-EGFR therapies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today